Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03868293 · ClinicalTrials.gov registry record · NA

Low Intensity Focused Ultrasound Epilepsy: A Pilot Trial

A NA study of Drug Resistant Epilepsy, sponsored by Brigham and Women's Hospital.

Recruiting
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT03868293 is a NA study of Drug Resistant Epilepsy that is actively recruiting participants, run by Brigham and Women's Hospital. The registered enrollment target is 10 participants, below the 35-participant average among 6 other Drug Resistant Epilepsy trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03868293, a NA study of Drug Resistant Epilepsy, is actively recruiting participants, sponsored by Brigham and Women's Hospital.

RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

The aim of the proposed pilot study is to investigate patient tolerability and efficacy of moderate term, repeated exposure of Pulsed Low-Intensity Focused Ultrasound (PLIFUS) in patients with drug-resistant temporal lobe epilepsy.

Conditions Studied

Interventions

  • DEVICE Focused ultrasound

Study Locations (1)

Massachusetts

  • Brigham and women's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2019-02-07
Est. Completion 2026-03-09
Phase NA

Sponsor

Brigham and Women's Hospital

937 total trials

What the Registry Record Tells You About NCT03868293

The ClinicalTrials.gov registry entry for NCT03868293 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 35-participant average among 6 other Drug Resistant Epilepsy trials with a reported enrollment target (71% lower). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Drug Resistant Epilepsy appearing as the primary indexed condition, and to 1 intervention - of which Focused ultrasound is the first listed.

NCT03868293 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT03868293 about?

NCT03868293 is a clinical study titled "Low Intensity Focused Ultrasound Epilepsy: A Pilot Trial". The aim of the proposed pilot study is to investigate patient tolerability and efficacy of moderate term, repeated exposure of Pulsed Low-Intensity Focused Ultrasound (PLIFUS) in patients with drug-resistant temporal lobe epilepsy.

What is the current status of trial NCT03868293?

This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2019-02-07. Estimated completion is 2026-03-09.

What conditions does trial NCT03868293 study?

This clinical trial studies the following conditions: Drug Resistant Epilepsy.

What interventions are being tested in trial NCT03868293?

The interventions under investigation include: Focused ultrasound (DEVICE).

Who is sponsoring clinical trial NCT03868293?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03868293 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Drug Resistant Epilepsy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.